BridgeMD
New treatment option for Fibromyalgia (FM)
Official title Between Paws and Affections - Impact of Dog-Assisted Therapy in Fibromyalgia Patients
ClinicalTrials.gov ID: NCT07356206
What this study is testing
- What it's testing
- The purpose of this study is to evaluate the effectiveness and medium-term maintenance of a structured dog-assisted therapy (DAT) protocol, "Entre Patas e Afetos" (Between Paws and Affections), in reducing pain, anxiety and depressive symptoms and in improving functional status and quality of life in Portuguese patients with fibromyalgia (FM) followed at ULS Alto Ave, with systematic outcome assessment in the immediate post intervention phase (T2), 6-month follow-up (T3) and 12-month follow-up (T4).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older
- Confirmed diagnosis of fibromyalgia
- Being followed at ULS Alto Ave by the Multidisciplinary Pain Unit, Internal Medicine (Auto immune diseases), Physical and Rehabilitation Medicine or...
- Ability to read and write Portuguese and to understand the study procedures
- Willingness and ability to participate voluntarily in the 10 session program and all scheduled assessments (T1-T4)
You likely can't join if
- Allergy to dogs or marked fear of dogs
- History of aggression towards animals
- History of oncological disease
- Concomitant systemic or rheumatologic disease that may confound pain and functional assessment
- Decompensated psychiatric disorder or severe cognitive impairment that may compromise comprehension of the protocol or adherence to the intervention
- Refusal to participate or withdrawal of consent at any point
See the full eligibility criteria
- Age 18 years or older
- Confirmed diagnosis of fibromyalgia
- Being followed at ULS Alto Ave by the Multidisciplinary Pain Unit, Internal Medicine (Auto immune diseases), Physical and Rehabilitation Medicine or Neurology
- Ability to read and write Portuguese and to understand the study procedures
- Willingness and ability to participate voluntarily in the 10 session program and all scheduled assessments (T1-T4)
- Provision of written informed consent
- Allergy to dogs or marked fear of dogs
- History of aggression towards animals
- History of oncological disease
- Concomitant systemic or rheumatologic disease that may confound pain and functional assessment
- Decompensated psychiatric disorder or severe cognitive impairment that may compromise comprehension of the protocol or adherence to the intervention
- Refusal to participate or withdrawal of consent at any point
The study team makes the final eligibility decision.
Where it's taking place
- Guimarães, Portugal
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guimarães, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.